Przerzutowanie w raku piersi – analiza wybranych mechanizmów molekularnych zjawiska

GLOSA LUB KOMENTARZ PRAWNICZY

Przerzutowanie w raku piersi – analiza wybranych mechanizmów molekularnych zjawiska

Jarosław Kozłowski 1 , Aleksandra Kozłowska 2 , Janusz Kocki 3

1. Department of Clinical Genetics, Medical University of Lublin; Department of Oncological Surgery, St. John’s Cancer Center, Lublin
2. Department of Clinical Genetics, Medical University of Lublin; Department of Radiotherapy, St. John’s Cancer Center, Lublin
3. Department of Clinical Genetics, Medical University of Lublin

Opublikowany: 2015-04-08
DOI: 10.5604/17322693.1148710
GICID: 01.3001.0009.6518
Dostępne wersje językowe: pl en
Wydanie: Postepy Hig Med Dosw 2015; 69 : 447-451

 

Abstrakt

Przypisy

  • 1. Aguirre-Ghiso J.A.: Models, mechanisms and clinical evidence forcancer dormancy. Nat. Rev. Cancer, 2007; 7: 834-846
    Google Scholar
  • 2. Albini A., Mirisola V., Pfeffer U.: Metastasis signatures: genes regulatingtumor-microenvironment interactions predict metastatic behavior.Cancer Metastasis Rev., 2008; 27: 75-83
    Google Scholar
  • 3. Avraamides C.J., Garmy-Susini B., Varner J.A.: Integrins in angiogenesisand lymphangiogenesis. Nat. Rev. Cancer, 2008; 8: 604-617
    Google Scholar
  • 4. Braun S., Vogl F.D., Naume B., Janni W., Osborne M.P., CoombesR.C., Schlimok G., Diel I.J., Gerber B., Gebauer G., Pierga J.Y., MarthC., Oruzio D., Wiedswang G., Solomayer E.F. et al.: A pooled analysis of bone marrow micrometastasis in breast cancer. N. Engl. J. Med.,2005; 353: 793-802
    Google Scholar
  • 5. Brooks S.A., Lomax-Browne H.J., Carter T.M., Kinch C.E., Hall D.M.:Molecular interactions in cancer cell metastasis. Acta Histochem., 2010;112: 3-25
    Google Scholar
  • 6. Chaffer C.L., Weinberg R.A.: A perspective on cancer cell metastasis.Science, 2011; 331: 1559-1564
    Google Scholar
  • 7. Christofori G., Semb H.: The role of the cell-adhesion molecule E-cadherinas a tumor-suppressor gene. Trends Biochem. Sci., 1999; 24: 73-76
    Google Scholar
  • 8. Ding L., Ellis M.J., Li S., Larson D.E., Chen K., Wallis J.W., Harris C.C.,McLellan M.D., Fulton R..S, Fulton L.L., Abbott R.M., Hoog J., DoolingD.J., Koboldt D.C., Schmidt H. et al.: Genome remodeling in a basal-likebreast cancer metastasis and xenograft. Nature, 2010; 464: 999-1005
    Google Scholar
  • 9. Erler J.T., Bennewith K.L., Nicolau M., Dornhöfer N., Kong C., Le Q.T.,Chi J.T., Jeffrey S.S., Giaccia A.J.: Lysyl oxidase is essential for hypoxia–induced metastasis. Nature, 2006; 440: 1222-1226
    Google Scholar
  • 10. Fidler I.J.: The pathogenesis of cancer metastasis: the ‘seed and soil’hypothesis revisited. Nat. Rev. Cancer, 2003; 3: 453-458
    Google Scholar
  • 11. Folkman J.: Angiogenesis in cancer, vascular, rheumatoid and otherdisease. Nat. Med., 1995; 1: 27-31
    Google Scholar
  • 12. Folkman J.: Antiangiogenesis in cancer therapy – endostatin and itsmechanisms of action. Exp. Cell. Res., 2006; 312: 594-607
    Google Scholar
  • 13. Goss P.E., Chambers A.F.: Does tumor dormancy offer a therapeutictarget? Nat. Rev. Cancer, 2010; 10: 871-877
    Google Scholar
  • 14. Hanahan D., Weinberg R.A.: Hallmarks of cancer: the next generation.Cell, 2011; 144: 646-674
    Google Scholar
  • 15. Harris A.L.: Hypoxia – a key regulatory factor in tumor growth. Nat.Rev. Cancer, 2002; 2: 38-47
    Google Scholar
  • 16. Hennessy B.T., Gonzalez-Angulo A.M., Stemke-Hale K., GilcreaseM.Z., Krishnamurthy S., Lee J.S., Fridlyand J., Sahin A., Agarwal R., JoyC., Liu W., Stivers D., Baggerly K., Carey M., Lluch A. et al.: Characterizationof a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymaltransition and stem cell characteristics. CancerRes., 2009; 69: 4116- 4124
    Google Scholar
  • 17. Kaplan R.N., Psaila B., Lyden D.: Bone marrow cells in the ‘pre–metastatic niche’: within bone and beyond. Cancer Metastasis Rev.,2006; 25: 521-529
    Google Scholar
  • 18. Kim M.Y., Oskarsson T., Acharyya S., Nguyen D.X., Zhang X.H., NortonL., Massagué J.: Tumor self-seeding by circulating cancer cells. Cell,2009; 139: 1315-1326
    Google Scholar
  • 19. Klein C.A.: Parallel progression of primary tumors and metastases.Nat. Rev. Cancer, 2009; 9: 302-312
    Google Scholar
  • 20. Laubli H., Borsig L.: Selectins promote tumor metastasis. Semin.Cancer Biol., 2010; 20: 169-177
    Google Scholar
  • 21. Lorusso G., Ruegg C.: New insights into the mechanisms of organ–specific breast cancer metastasis. Semin. Cancer Biol., 2012; 22: 226-233
    Google Scholar
  • 22. Lorusso G., Ruegg C.: The tumor microenvironment and its contributionto tumor evolution toward metastasis. Histochem. Cell Biol.,2008; 130: 1091-1103
    Google Scholar
  • 23. Luzzi K.J., MacDonald I.C., Schmidt EE, Kerkvliet N., Morris V.L.,Chambers A.F., Groom A.C.: Multistep nature of metastatic inefficiency:dormancy of solitary cells after successful extravasation and limitedsurvival of early micrometastases. Am. J. Pathol., 1998; 153: 865-873
    Google Scholar
  • 24. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E.,McClanahan T., Murphy E., Yuan W., Wagner S.N., Barrera J.L., MoharA., Verastegui E., Zlotnik A.: Involvement of chemokine receptors inbreast cancer metastasis. Nature, 2001; 410: 50-56
    Google Scholar
  • 25. Paget S.: The distribution of secondary growths in cancer of thebreast. Cancer Metastasis Rev., 1989; 8: 98-101
    Google Scholar
  • 26. Pantel K., Brakenhoff R.H.: Dissecting the metastatic cascade. Nat.Rev. Cancer, 2004; 4: 448-456
    Google Scholar
  • 27. Rabbani S.A., Mazar A.P.: Evaluating distant metastases in breastcancer: from biology to outcomes. Cancer Metastasis Rev., 2007; 26:663-674
    Google Scholar
  • 28. Ramaswamy S., Ross K.N., Lander E.S., Golub T.R.: A molecular signatureof metastasis in primary solid tumors. Nat. Genet., 2003; 33: 49-54
    Google Scholar
  • 29. Reynolds L.P., Redmer D.A.: Angiogenesis in the placenta. Biol. Reprod.,2001; 64: 1033-1040
    Google Scholar
  • 30. Sarrio D., Rodriguez-Pinilla S.M., Hardisson D., Cano A., Moreno–Bueno G., Palacios J.: Epithelial-mesenchymal transition in breast cancerrelates to the basal-like phenotype. Cancer Res., 2008; 68: 989-997
    Google Scholar
  • 31. Spano D., Heck C., De Antonellis P., Christofori G., Zollo M.: Molecularnetworks that regulate cancer metastasis. Semin. Cancer Biol.,2012; 22: 234-249
    Google Scholar
  • 32. Steeg P.S.: Tumor metastasis: mechanistic insights and clinical challenges.Nat. Med., 2006; 12: 895-904
    Google Scholar
  • 33. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A.: Epithelial-mesenchymaltransitions in development and disease. Cell, 2009; 139: 871-890
    Google Scholar
  • 34. Thomas P.A., Kirschmann D.A., Cerhan J.R., Folberg R., Seftor E.A.,Sellers T.A., Hendrix M.J.: Association between keratin and vimentinexpression, malignant phenotype, and survival in postmenopausal breastcancer patients. Clin. Cancer Res., 1999; 5: 2698-2703
    Google Scholar
  • 35. Tse J.C., Kalluri R.: Mechanisms of metastasis: epithelial-to-mesenchymaltransition and contribution of tumor microenvironment. J. CellBiochem., 2007; 101: 816-829
    Google Scholar
  • 36. Valastyan S., Weinberg R.A.: Tumor metastasis: molecular insightsand evolving paradigms. Cell, 2011; 147: 275-292
    Google Scholar
  • 37. Weidner N., Folkman J., Pozza F., Bevilacqua P., Allred E.N., MooreD.H., Meli S., Gasparini G.: Tumor angiogenesis: a new significant andindependent prognostic indicator in early-stage breast carcinoma. J.Natl. Cancer Inst., 1992; 84: 1875-1887
    Google Scholar
  • 38. Weil R.J., Palmieri D.C., Bronder J.L., Stark A.M., Steeg P.S.: Breastcancer metastasis to the central nervous system. Am. J. Pathol., 2005;167: 913-920
    Google Scholar

Pełna treść artykułu

Przejdź do treści